Seelos Therapeutics

$1.03
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.13 (+14.78%) Today
$0.00 (0.00%) As of 5:00 PM EST after-hours

Why Robinhood?

You can buy or sell SEEL and other stocks, options, and ETFs commission-free!

About SEEL

Seelos Therapeutics, Inc. Common Stock, also called Seelos Therapeutics, is a clinical-stage biopharmaceutical company. It focuses on development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system disorders. Its portfolio includes late-stage clinical assets targeting psychiatric and movement disorders. The company is headquartered in New York, NY. The listed name for SEEL is Seelos Therapeutics, Inc. Common Stock.

CEO
Raj Mehra
Employees
6
Headquarters
New York, New York
Founded
Market Cap
55.03M
Price-Earnings Ratio
Dividend Yield
Average Volume
871.35K
High Today
$1.05
Low Today
$0.902
Open Price
$0.902
Volume
2.89M
52 Week High
$1.71
52 Week Low
$0.4195

Collections

SEEL Earnings

-$3.98
-$2.65
-$1.33
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 16, After Hours

You May Also Like